All In MedTech

FDA Clearance Tracker · P130028-S025

Algovita Spinal Cord Stimulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 31, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 31, 2019

Approved

Time to decision

207 days

Received Jun 7, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P130028-S025
Device name
Algovita Spinal Cord Stimulation System
Applicant location
Blaine, MN
Received
Jun 7, 2019
Decided
Dec 31, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P130028

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for whole-body MRI labeling indication for implanted components of the Algovita SCS System for use in closed bore, horizontal, static magnetic field strength of 1.5T MR environments.

Source documents

Other decisions for Nuvectra Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.